Cediranib and chemo combo improves PFS for metastatic cervical cancer
Cediranib and chemo combo improves PFS for metastatic cervical cancer
Pertuzumab adds 16 months survival benefit to trastuzumab plus chemotherapy for HER2-positive metastatic breast cancer
Adding cediranib to chemo improves PFS for metastatic cervical cancer
Reducing nausea and vomiting associated with cisplatin-based chemotherapy with rolapitant
The evolving treatment landscape for HER2-positive metastatic breast cancer
Navigating current treatment options for HER2-positive MBC: Patient journey 1
Overview of skin cancer treatments, past, present and future
Advances in CLL: Expert panel Discussion
Emerging treatments in CLL: Expert Discussion
Melanoma live: Making patient-focused therapy decisions
Repurposing generics to fight cancer and the work of the ReDO Project
Looking for biomarkers in metronomic chemotherapy